Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Davis Polk Advises Kadmon Holdings, Inc. on Its Follow-on Offerings of Common Stock and Warrants to Purchase Common Stock
Davis Polk advised Kadmon Holdings, Inc. in connection with an $80.4 million offering of 22,275,000 shares of common stock…
Juno Therapeutics, Inc. $288 Million Follow-On Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a…
Magellan Health, Inc. $400 Million Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of …
Zai Lab Limited Initial Public Offering and NASDAQ Listing
Davis Polk advised the joint book-running managers and representatives of the underwriters on the $172.5 million…
Healthcare Trust of America, Inc. $500 Million At-the-Market Offering
Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting…
Portola Pharmaceuticals Follow-On Offering
Davis Polk advised the joint book-running managers and the co-managers in connection with the $349.3 million…
Zoetis Inc. $1.25 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc…
Jazz Pharmaceuticals $500 Million Exchangeable Senior Notes Offering
Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned…
Oxford Immunotec Global PLC Offering of Ordinary Shares
Davis Polk advised the underwriter in connection with the $39.3 million SEC-registered offering of 2,500,000 ordinary…
BeiGene, Ltd. Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters on the $201 million public…